• A potentially more effective treatment for HER2 mutant metastatic breast cancer

    10 days ago - By ScienceDaily

    Researchers have identified a HER2 mutation that confers therapeutic resistance and promotes metastatic behavior in lobular breast cancer. Importantly, they also showed that the drug poziotinib, which is already approved for other cancer types, reduced tumor growth and multi-organ metastasis in laboratory tests and animal models. A phase II clinical trial is on the works to determine the value of this drug in the treatment of patients with this devastating condition.
    Read more ...

     

  • New biomarkers unlock potential for more effective treatment of deadly cancers

    10 days ago - By ScienceDaily

    A new study focused on decoding the genetic chaos found in cancer cells reveals novel biomarkers with the potential to improve the development of precision therapies and treatment selection for the deadliest types of cancer.
    Read more ...

     

  • Novel liquid biopsy test can quickly identify cancer DNA in patients with metastatic breast cancer

    10 days ago - By News Medical

    A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours.
    Read more ...